584 related articles for article (PubMed ID: 31931147)
1. Activity of pulmonary vancomycin exposures versus planktonic and biofilm isolates of methicillin-resistant Staphylococcus aureus from cystic fibrosis sputum.
Britt NS; Hazlett DS; Horvat RT; Liesman RM; Steed ME
Int J Antimicrob Agents; 2020 Apr; 55(4):105898. PubMed ID: 31931147
[TBL] [Abstract][Full Text] [Related]
2. In vitro efficacy of antimicrobial agents against high-inoculum or biofilm-embedded meticillin-resistant Staphylococcus aureus with vancomycin minimal inhibitory concentrations equal to 2 μg/mL (VA2-MRSA).
Tang HJ; Chen CC; Ko WC; Yu WL; Chiang SR; Chuang YC
Int J Antimicrob Agents; 2011 Jul; 38(1):46-51. PubMed ID: 21549575
[TBL] [Abstract][Full Text] [Related]
3. In vitro antibacterial effects of Tanreqing injection combined with vancomycin or linezolid against methicillin-resistant Staphylococcus aureus.
Yang W; Liu J; Blažeković B; Sun Y; Ma S; Ren C; Vladimir-Knežević S; Li C; Xing Y; Tian G; Wang Y
BMC Complement Altern Med; 2018 May; 18(1):169. PubMed ID: 29848316
[TBL] [Abstract][Full Text] [Related]
4. Effects of sub-inhibitory concentrations of nafcillin, vancomycin, ciprofloxacin, and rifampin on biofilm formation of clinical methicillin-resistant
Park K-H; Kim D; Jung M; Kim DY; Lee Y-M; Lee MS; Hong K-W; Bae I-G; Hong SI; Cho O-H
Microbiol Spectr; 2024 Jun; 12(6):e0341223. PubMed ID: 38651875
[TBL] [Abstract][Full Text] [Related]
5. Antibiotic Tolerance and Treatment Outcomes in Cystic Fibrosis Methicillin-Resistant Staphylococcus aureus Infections.
Lu KY; Wagner NJ; Velez AZ; Ceppe A; Conlon BP; Muhlebach MS
Microbiol Spectr; 2023 Feb; 11(1):e0406122. PubMed ID: 36519944
[TBL] [Abstract][Full Text] [Related]
6. Activities of daptomycin and vancomycin alone and in combination with rifampin and gentamicin against biofilm-forming methicillin-resistant Staphylococcus aureus isolates in an experimental model of endocarditis.
LaPlante KL; Woodmansee S
Antimicrob Agents Chemother; 2009 Sep; 53(9):3880-6. PubMed ID: 19564363
[TBL] [Abstract][Full Text] [Related]
7. Impact of biofilm on the in vitro activity of vancomycin alone and in combination with tigecycline and rifampicin against Staphylococcus aureus.
Rose WE; Poppens PT
J Antimicrob Chemother; 2009 Mar; 63(3):485-8. PubMed ID: 19109338
[TBL] [Abstract][Full Text] [Related]
8. Effect of ZnO nanoparticles on methicillin, vancomycin, linezolid resistance and biofilm formation in Staphylococcus aureus isolates.
Abdelraheem WM; Khairy RMM; Zaki AI; Zaki SH
Ann Clin Microbiol Antimicrob; 2021 Aug; 20(1):54. PubMed ID: 34419054
[TBL] [Abstract][Full Text] [Related]
9. Role of Extracellular DNA in Dalbavancin Activity against Methicillin-Resistant Staphylococcus aureus (MRSA) Biofilms in Patients with Skin and Soft Tissue Infections.
Sivori F; Cavallo I; Kovacs D; Guembe M; Sperduti I; Truglio M; Pasqua M; Prignano G; Mastrofrancesco A; Toma L; Pimpinelli F; Morrone A; Ensoli F; Di Domenico EG
Microbiol Spectr; 2022 Apr; 10(2):e0035122. PubMed ID: 35416701
[TBL] [Abstract][Full Text] [Related]
10. Telavancin shows superior activity to vancomycin with multidrug-resistant Staphylococcus aureus in a range of in vitro biofilm models.
Smith K; Gemmell CG; Lang S
Eur J Clin Microbiol Infect Dis; 2013 Oct; 32(10):1327-32. PubMed ID: 23624635
[TBL] [Abstract][Full Text] [Related]
11. In vitro bactericidal activity of levonadifloxacin (WCK 771) against methicillin- and quinolone-resistant Staphylococcus aureus biofilms.
Tellis M; Joseph J; Khande H; Bhagwat S; Patel M
J Med Microbiol; 2019 Aug; 68(8):1129-1136. PubMed ID: 31241446
[TBL] [Abstract][Full Text] [Related]
12. Comparison of biofilm-associated cell survival following in vitro exposure of meticillin-resistant Staphylococcus aureus biofilms to the antibiotics clindamycin, daptomycin, linezolid, tigecycline and vancomycin.
Smith K; Perez A; Ramage G; Gemmell CG; Lang S
Int J Antimicrob Agents; 2009 Apr; 33(4):374-8. PubMed ID: 19101124
[TBL] [Abstract][Full Text] [Related]
13. Activity of Telavancin against Staphylococcus aureus Isolates, Including Those with Decreased Susceptibility to Ceftaroline, from Cystic Fibrosis Patients.
Roch M; Varela MC; Taglialegna A; Rose WE; Rosato AE
Antimicrob Agents Chemother; 2018 Sep; 62(9):. PubMed ID: 29914961
[TBL] [Abstract][Full Text] [Related]
14.
Orazi G; O'Toole GA
mBio; 2017 Jul; 8(4):. PubMed ID: 28720732
[TBL] [Abstract][Full Text] [Related]
15. Oritavancin Combinations with β-Lactams against Multidrug-Resistant Staphylococcus aureus and Vancomycin-Resistant Enterococci.
Smith JR; Yim J; Raut A; Rybak MJ
Antimicrob Agents Chemother; 2016 Apr; 60(4):2352-8. PubMed ID: 26833159
[TBL] [Abstract][Full Text] [Related]
16. Synergistic bactericidal effects of phage-enhanced antibiotic therapy against MRSA biofilms.
Kunz Coyne AJ; Stamper K; Bleick C; Kebriaei R; Lehman SM; Rybak MJ
Microbiol Spectr; 2024 Apr; 12(4):e0321223. PubMed ID: 38411110
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of Ceftaroline Alone and in Combination against Biofilm-Producing Methicillin-Resistant Staphylococcus aureus with Reduced Susceptibility to Daptomycin and Vancomycin in an In Vitro Pharmacokinetic/Pharmacodynamic Model.
Barber KE; Smith JR; Ireland CE; Boles BR; Rose WE; Rybak MJ
Antimicrob Agents Chemother; 2015 Aug; 59(8):4497-503. PubMed ID: 25987623
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of vancomycin in combination with piperacillin-tazobactam or oxacillin against clinical methicillin-resistant Staphylococcus aureus Isolates and vancomycin-intermediate S. aureus isolates in vitro.
Dilworth TJ; Sliwinski J; Ryan K; Dodd M; Mercier RC
Antimicrob Agents Chemother; 2014; 58(2):1028-33. PubMed ID: 24277036
[TBL] [Abstract][Full Text] [Related]
19. The Virulence Potential of Livestock-Associated Methicillin-Resistant
Treffon J; Fotiadis SA; van Alen S; Becker K; Kahl BC
Toxins (Basel); 2020 May; 12(6):. PubMed ID: 32486247
[No Abstract] [Full Text] [Related]
20. Phase I, Dose-Escalating Study of the Safety and Pharmacokinetics of Inhaled Dry-Powder Vancomycin (AeroVanc) in Volunteers and Patients with Cystic Fibrosis: a New Approach to Therapy for Methicillin-Resistant Staphylococcus aureus.
Waterer G; Lord J; Hofmann T; Jouhikainen T
Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31964790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]